PEG10 and breast carcinoma: Additionally, upregulated expression of PEG10 has been observed in malignancies such as hepatocellular carcinoma, bladder cancer, lung cancer, breast cancer, pancreatic cancer [21], and cutaneous T-cell lymphoma [20].